open access

Vol 65, No 1 (2014)
Original papers
Published online: 2014-02-19
Submitted: 2014-02-19
Accepted: 2014-02-19
Get Citation

Proinsulin, adiponectin and hsCRP in reproductive age women with polycystic ovary syndrome (PCOS) — the effect of metformin treatment

Aleksandra Kruszyńska, Jadwiga Słowińska-Srzednicka, Wojciech Jeske, Wojciech Zgliczyński
DOI: 10.5603/EP.2014.0001
·
Endokrynologia Polska 2014;65(1):2-10.

open access

Vol 65, No 1 (2014)
Original papers
Published online: 2014-02-19
Submitted: 2014-02-19
Accepted: 2014-02-19

Abstract

Introduction: Women with polycystic ovary syndrome (PCOS) often suffer from obesity and insulin resistance. The role of proinsulin, which is known to be an indicator of fertility outcomes in PCOS women, and that of adiponectin, in the pathogenesis of PCOS is not well elucidated. Our objective was to determine proinsulin, adiponectin, hsCRP and other hormonal and metabolic parameters in PCOS women before and after metformin treatment.

Material and methods: Two PCOS groups of patients of reproductive age (90 lean and 88 obese or overweight) with two control groups, adjusted for body mass index (BMI), were compared at baseline. 32 PCOS women were studied at baseline, after three and six months of metformin (1,000 mg/day) treatment. Clinical, anthropometric, biochemical and hormonal parameters were assessed.

Results: Proinsulin and hsCRP levels were the highest in obese PCOS women and were statistically different than in lean PCOS women (proinsulin: 11.4 v. 6.9 pmol/L; hsCRP 2.46 v. 0.47 mg/L, p < 0.01) and than in obese controls. Levels of adiponectin were dependant on BMI. Plasma proinsulin and androstenedione levels decreased after metformin treatment only in obese PCOS women.

Conclusions: PCOS, when accompanied by obesity, is associated with elevated proinsulin concentrations, which correlates with higher hsCRP and increased FAI. Proinsulin level decreases due to metformin treatment. Our results suggest that obese or overweight PCOS and lean PCOS are characterised by different hormonal and metabolic parameters and have a different response to metformin treatment. (Endokrynol Pol 2014; 65 (1): 2–10)

Abstract

Introduction: Women with polycystic ovary syndrome (PCOS) often suffer from obesity and insulin resistance. The role of proinsulin, which is known to be an indicator of fertility outcomes in PCOS women, and that of adiponectin, in the pathogenesis of PCOS is not well elucidated. Our objective was to determine proinsulin, adiponectin, hsCRP and other hormonal and metabolic parameters in PCOS women before and after metformin treatment.

Material and methods: Two PCOS groups of patients of reproductive age (90 lean and 88 obese or overweight) with two control groups, adjusted for body mass index (BMI), were compared at baseline. 32 PCOS women were studied at baseline, after three and six months of metformin (1,000 mg/day) treatment. Clinical, anthropometric, biochemical and hormonal parameters were assessed.

Results: Proinsulin and hsCRP levels were the highest in obese PCOS women and were statistically different than in lean PCOS women (proinsulin: 11.4 v. 6.9 pmol/L; hsCRP 2.46 v. 0.47 mg/L, p < 0.01) and than in obese controls. Levels of adiponectin were dependant on BMI. Plasma proinsulin and androstenedione levels decreased after metformin treatment only in obese PCOS women.

Conclusions: PCOS, when accompanied by obesity, is associated with elevated proinsulin concentrations, which correlates with higher hsCRP and increased FAI. Proinsulin level decreases due to metformin treatment. Our results suggest that obese or overweight PCOS and lean PCOS are characterised by different hormonal and metabolic parameters and have a different response to metformin treatment. (Endokrynol Pol 2014; 65 (1): 2–10)

Full Text:

View HTML
Get Citation

Keywords

PCOS; proinsulin, insulin resistance; adiponectin; C-reactive protein; obesity

About this article
Title

Proinsulin, adiponectin and hsCRP in reproductive age women with polycystic ovary syndrome (PCOS) — the effect of metformin treatment

Journal

Endokrynologia Polska

Issue

Vol 65, No 1 (2014)

Pages

2-10

Published online

2014-02-19

DOI

10.5603/EP.2014.0001

Bibliographic record

Endokrynologia Polska 2014;65(1):2-10.

Keywords

PCOS
proinsulin
insulin resistance
adiponectin
C-reactive protein
obesity

Authors

Aleksandra Kruszyńska
Jadwiga Słowińska-Srzednicka
Wojciech Jeske
Wojciech Zgliczyński

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl